Business Standard

PM visits Bharat Biotech in Hyderabad to take stock of vaccine development

Modi visited drugmaker Zydus Cadila's plant near Ahmedabad earlier in the day.

Prime Minister Narendra Modi visits Bharat Biotech facility to review COVID19 vaccine development in Hyderabad | ANI

PM Narendra Modi visits Bharat Biotech's facility in Hyderabad to review Covid-19 vaccine development | ANI

Press Trust of India Hyderabad
Prime Minister Narendra Modi arrived here on Saturday as part of his three-city tour to take the stock of COVID-19 vaccine development.
After landing at Hakimpet Air Force station here, he was received by Telangana Chief Secretary Somesh Kumar, Director General of Police and other officials.
He will be proceeding to Bharat Biotech's facility located at Genome valley, a life sciences cluster about 20 km from the AF base, officials said.
Covid-19 vaccine, Covaxin, being developed byBharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virologyis now undergoing phase-3 trials.
The vaccine is being developed and will be manufactured at Bharat Biotech's BSL-3 (Bio-Safety Level 3) facility in Genome Valley in Hyderabad.
Modi will be interacting with scientists and senior management of the city-based vaccine maker onthe status of Covaxin, officials said.
The PM will be flying back to the national capital after a stopover inPune, where he will visit the Serum Institute of India (SII), which has partnered with pharma giant AstraZeneca and the Oxford University for the vaccine.
Earlier in the morning, Modi visited Zydus Cadila's plant near Ahmedabad.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 28 2020 | 1:48 PM IST

Explore News